E-Cigarettes Can Be Used As A First-line Aid For Smoking Cessation In Adults

Published On: 21 Feb, 2023 4:06 PM | Updated On: 15 May, 2024 4:51 AM

E-Cigarettes Can Be Used As A First-line Aid For Smoking Cessation In Adults

A global survey for the acceptability of electronic cigarettes or vapes as an effective tool to treat nicotine addiction was carried out by Kenneth Warner, dean emeritus from the University of Michigan's School of Public Health and his team. Warner and colleagues published a study in Nature Medicine, observing the global view of vaping and investigating countries that promote vaping as a smoking cessation strategy and countries that don't. They found that the agencies in the United States and Canada acknowledge the potential importance of e-cigarette use but consider the evidence to recommend e-cigarettes for smoking cessation insufficient. However, the United Kingdom and New Zealand show high-level support and promote e-cigarettes as a first-line smoking cessation treatment option.

 

Along with evaluating differences in regulatory activities across countries, the researchers examined evidence that vaping improves smoking cessation, the health consequences of e-cigarettes, and the relevance for clinical care.

 

They also mentioned that the Food and Drug Administration symbolizes some e-cigarette brands as appropriate for public health protection, which is the standard need for marketing approval. The researchers stated, "This move indirectly points out that the FDA consents that e-cigarettes can assist some individuals who would otherwise not quit smoking."

 

Kenneth Warner stated that "enough evidence supports e-cigarettes' use as a first-line aid for smoking cessation in adults." Hence smokers and healthcare professionals must appreciate their potential value.

 

The authors thus conclude that accepting the promotion of e-cigarettes as an armamentarium for smoking cessation is crucial.

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks